| Literature DB >> 33068718 |
Giovanna Cenini1, Matthias Hebisch2, Vira Iefremova1, Lea J Flitsch1, Yannik Breitkreuz3, Rudolph E Tanzi2, Doo Yeon Kim2, Michael Peitz4, Oliver Brüstle5.
Abstract
The incidence of Alzheimer's disease is increasing with the aging population, and it has become one of the main health concerns of modern society. The dissection of the underlying pathogenic mechanisms and the development of effective therapies remain extremely challenging, also because available animal and cell culture models do not fully recapitulate the whole spectrum of pathological changes. The advent of human pluripotent stem cells and cell reprogramming has provided new prospects for tackling these challenges in a human and even patient-specific setting. Yet, experimental modeling of non-cell autonomous and extracellular disease-related alterations has remained largely inaccessible. These limitations are about to be overcome by advances in the development of 3D cell culture systems including organoids, neurospheroids and matrix-embedded 3D cultures, which have been shown to recapitulate extracellular pathologies such as plaque formation in vitro. Recent xenograft studies have even taken human stem cell-based disease modeling to an in vivo scenario where grafted neurons are probed in a disease background in the context of a rodent brain. Here, we review the latest developments in this emerging field along with their advantages, challenges, and future prospects.Entities:
Keywords: 3D matrix; Alzheimer’s disease; Organoids; Spheroids; Xenograft; iPSC
Year: 2020 PMID: 33068718 DOI: 10.1016/j.mcn.2020.103568
Source DB: PubMed Journal: Mol Cell Neurosci ISSN: 1044-7431 Impact factor: 4.314